• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Seelos Therapeutics, Inc. - Common Stock (NQ:SEEL)

1.280 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Seelos Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
News headline image
6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD ↗
February 17, 2023
A look at the performance of the six largest psychedelic stocks by market capitalization. 
Via Talk Markets
News headline image
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today ↗
February 17, 2023
 
Via Benzinga
News headline image
Cybin, Compass Pathways Among Top Psychedelic Movers Of Today ↗
February 16, 2023
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 15, 2023 ↗
February 15, 2023
 
Via Benzinga
News headline image
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today ↗
February 14, 2023
 
Via Benzinga
News headline image
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today ↗
February 13, 2023
 
Via Benzinga
News headline image
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More ↗
February 13, 2023
Psychedelics Legislation: The Latest On Hawaii, Virginia, Missouri & More 
Via Benzinga
Psychedelics Are Proving Their Mettle Against Trauma, Anxiety
February 13, 2023
Via Investor Brand Network
Topics Cannabis
News headline image
"Multi-Bagger" Portfolio Update ↗
February 12, 2023
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022. I'm tracking 12 microcap stocks that might bounce back with major returns - dare I say 
Via Talk Markets
News headline image
Major Psychedelic Compound-Based Stocks UP 13% YTD ↗
February 11, 2023
We track the performance of the 6 largest companies researching the treatment of mental illnesses based on the use of one or more of 10 different psychedelic compound-based substances. 
Via Talk Markets
News headline image
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
February 10, 2023
 
Via Benzinga
News headline image
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗
February 09, 2023
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 8, 2023 ↗
February 08, 2023
 
Via Benzinga
News headline image
Seelos Dosing Participants In Psychedelics Study, Seeks Japanese Subjects In Major Depression Therapy ↗
February 07, 2023
Clinical-stage biopharma psychedelics company Seelos Therapeutics Inc. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 7, 2023 ↗
February 07, 2023
 
Via Benzinga
News headline image
The "Multi-Bagger" Portfolio Continued To Outperform The S&P 500 Last Week ↗
February 06, 2023
Our basket of mostly microcap cannabis, psychedelic and plant-based food stocks was extremely oversold in 2022 but we're watching for them to bounce back in 2023. 
Via Talk Markets
News headline image
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today ↗
February 06, 2023
 
Via Benzinga
News headline image
6 Largest Psychedelic Stocks Down 3% This Week ↗
February 04, 2023
The six largest of the 40 companies researching the treatment of mental illnesses by using psychedelic substances, which constitute our Psychedelic Drug Stocks Index, are now up 13% YTD despite a loss... 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From February 3, 2023 ↗
February 03, 2023
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 2, 2023 ↗
February 02, 2023
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 1, 2023 ↗
February 01, 2023
 
Via Benzinga
News headline image
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today ↗
January 31, 2023
 
Via Benzinga
News headline image
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today ↗
January 30, 2023
 
Via Benzinga
News headline image
The "Multi-Bagger" Portfolio Update: Week Ending January 27 ↗
January 29, 2023
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 but many of them could possibly bounce back with major returns in 2023. We track the performance of a basket of 10 such... 
Via Talk Markets
News headline image
Largest Psychedelic Stocks +1.2% This Week; Now +16.1% YTD ↗
January 28, 2023
We track the 6 largest psychedelic stocks that research the treatment of mental illnesses based on the use of one or more psychedelic substances - weekly and YTD results. 
Via Talk Markets
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
January 27, 2023
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 26, 2023 ↗
January 26, 2023
 
Via Benzinga
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today ↗
January 25, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023 ↗
January 24, 2023
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 23, 2023 ↗
January 23, 2023
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap